MAPT and Alzheimer disease: In animal model, Kim (2020) observes that frequent FMT from wild-type mice to AD-like pathology with amyloid and neurofibrillary tangles (ADLPAPT) transgenic mouse has decreased the formation of β-amyloid and tau protein in the ADLPAPT mice brain [125].